Copeland Capital Management LLC Boosts Stake in Chemed Corporation $CHE

Copeland Capital Management LLC grew its position in shares of Chemed Corporation (NYSE:CHE) by 7.6% in the first quarter, Holdings Channel reports. The fund owned 147,957 shares of the company’s stock after buying an additional 10,406 shares during the quarter. Chemed makes up about 1.2% of Copeland Capital Management LLC’s portfolio, making the stock its 28th biggest position. Copeland Capital Management LLC’s holdings in Chemed were worth $55,889,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Monetary Solutions Ltd bought a new stake in shares of Chemed in the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC bought a new position in shares of Chemed in the fourth quarter worth about $26,000. BOK Financial Private Wealth Inc. purchased a new position in shares of Chemed during the fourth quarter worth approximately $27,000. Global Retirement Partners LLC boosted its holdings in shares of Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares during the period. Finally, Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 3.33% of the stock is owned by corporate insiders.

Chemed Stock Up 1.7%

CHE stock opened at $509.89 on Friday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $511.85. The stock has a market capitalization of $6.77 billion, a PE ratio of 27.79, a price-to-earnings-growth ratio of 1.85 and a beta of 0.52. The firm has a 50 day moving average of $450.37 and a 200 day moving average of $430.92.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same period in the previous year, the company earned $5.63 earnings per share. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Sell-side analysts forecast that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is presently 13.08%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Bank of America lifted their target price on Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada lifted their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Finally, Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $480.25.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.